Bank of New York Mellon Corp Has $732,000 Holdings in Nature’s Sunshine Products, Inc. (NASDAQ:NATR)

Bank of New York Mellon Corp lifted its stake in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 12.6% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 48,589 shares of the company’s stock after acquiring an additional 5,425 shares during the period. Bank of New York Mellon Corp owned 0.26% of Nature’s Sunshine Products worth $732,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Jump Financial LLC bought a new stake in shares of Nature’s Sunshine Products during the 4th quarter worth $208,000. Trexquant Investment LP bought a new stake in Nature’s Sunshine Products in the fourth quarter worth $217,000. Wasatch Advisors LP bought a new position in Nature’s Sunshine Products during the 4th quarter worth approximately $7,430,000. BNP Paribas Financial Markets increased its stake in shares of Nature’s Sunshine Products by 12.7% in the first quarter. BNP Paribas Financial Markets now owns 15,207 shares of the company’s stock worth $316,000 after buying an additional 1,715 shares during the period. Finally, Janney Montgomery Scott LLC boosted its holdings in shares of Nature’s Sunshine Products by 8.9% during the first quarter. Janney Montgomery Scott LLC now owns 25,200 shares of the company’s stock worth $523,000 after purchasing an additional 2,054 shares during the period. 79.40% of the stock is currently owned by institutional investors and hedge funds.

Nature’s Sunshine Products Stock Performance

Nature’s Sunshine Products stock opened at $13.56 on Monday. Nature’s Sunshine Products, Inc. has a fifty-two week low of $10.81 and a fifty-two week high of $21.72. The company has a 50 day moving average price of $14.33 and a 200-day moving average price of $16.21. The company has a market capitalization of $253.98 million, a PE ratio of 15.95 and a beta of 0.87.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). The business had revenue of $110.55 million during the quarter. Nature’s Sunshine Products had a return on equity of 9.79% and a net margin of 3.50%.

Analysts Set New Price Targets

NATR has been the topic of several research reports. Canaccord Genuity Group began coverage on Nature’s Sunshine Products in a report on Friday, September 13th. They set a “buy” rating and a $18.00 target price on the stock. Canaccord Genuity Group initiated coverage on Nature’s Sunshine Products in a report on Friday, September 13th. They set a “buy” rating and a $18.00 price target on the stock. DA Davidson reduced their target price on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating for the company in a report on Monday, August 12th. Finally, StockNews.com raised Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 10th.

About Nature’s Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.